STUDIES OF THYROID FUNCTION USING 99Tcm IN THYROTOXIC PATIENTS DURING TREATMENT WITH ANTITHYROID DRUGS
Authors:
- 1 January 1973
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 2 (1) , 65-73
Abstract
SUMMARY: Serial measurements of 99Tcm uptake have been made in thirty thyrotoxic patients treated with carbimazole and L‐triiodothyronine. All patients were followed up for a minimum period of 1 year at which time eighteen patients were still in remission and twelve had relapsed.Four of the twenty‐one patients who had a normal 99Tcm uptake at the time treatment was discontinued relapsed within 6 months. Only one of the nine patients whose uptake at the end of treatment was above normal achieved a remission. Changes in 99Tcm uptake during the first 6 months of treatment were less informative and proved to be of limited value in predicting the outcome of treatment.In the whole group of patients 99Tcm uptake fell during the first 6 months by about 40%, this change being highly significant. The decline in thyroid activity coincided with the time at which treatment was started. It is suggested that treatment with an antithyroid drug may modify the course of the disease.Keywords
This publication has 8 references indexed in Scilit:
- A simple, rapid method for measuring the thyroidal uptake of99Tcmby profile scanningBritish Journal of Radiology, 1972
- Use of"Tcm for the Routine Assessment of Thyroid FunctionBMJ, 1971
- Thyroid Suppressibility: Follow-up for Two Years after Antithyroid TreatmentBMJ, 1971
- Diagnostic Value of 20 Minute 99mTc Pertechnetate Thyroid UptakeNuklearmedizin-Nuclear Medicine, 1971
- Prediction of the Long-Term Results of Antithyroid Drug Therapy for ThyrotoxicosisThe Journal of Clinical Endocrinology & Metabolism, 1970
- Measurement of the uptake of99mTc by the thyroidBritish Journal of Radiology, 1968
- Development of Thyroidal Suppression by Triiodothyronine During Six Months' Treatment of Thyrotoxicosis with Antithyroid DrugsThe Journal of Clinical Endocrinology & Metabolism, 1967
- THYROIDAL SUPPRESSION BY TRIIODOTHYRONINE AS A GUIDE TO DURATION OF TREATMENT OF THYROTOXICOSIS WITH ANTITHYROID DRUGSThe Lancet, 1966